Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...

Shares in the brain drug developer rose by more than 20% Monday on news of the deal, which will forestall Teva's generic copy ...

Patents require reliability so they can incentivize investments in new technologies, their primary though little-noticed ...

Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company dedicated to the development of ...

Adcentrx Therapeutics Inc. and Adcentrx Therapeutics Shanghai Co. Ltd. have disclosed antibody-drug conjugates comprising a monoclonal antibody covalently bound to a cytotoxic drug through a linker.

The patent refers to the Company’s innovative ... including Palmitoylethanolamide (PEA). About Clearmind Medicine Inc. Clearmind is a clinical-stage psychedelic pharmaceutical biotech company ...

Lydia E. Pinkham’s Vegetable Compound was one of thousands of popular and lucrative patent medicines—health concoctions dreamed up by chemists, housewives, and entrepreneurs—that took the ...

Pharma consultant Sanjay Agrawal seeks patent for a new drug formulation targeting cellular ageing, aiming to improve skin health, energy, and vitality.